| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.8 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |